Overview

Maintenance Therapy Using Lenalidomide in Myeloma

Status:
Completed
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
Maintenance treatment of myeloma.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Toulouse
Collaborators:
Celgene
Celgene Corporation
Intergroupe Francophone du Myelome
Treatments:
Lenalidomide
Thalidomide